Khurram Nasir, MD MPH MSc

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Amgen
    Topic:
    CV Prevention
    Date added:
    05/11/2026
    Date updated:
    05/11/2026
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Novartis
    Topic:
    CV prevention
    Date added:
    05/11/2026
    Date updated:
    05/11/2026
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Novo Nordisk
    Topic:
    CV prevention
    Date added:
    05/11/2026
    Date updated:
    05/11/2026
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Esperion
    Topic:
    CV Prevention
    Date added:
    05/11/2026
    Date updated:
    05/11/2026
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Corsera Health
    Topic:
    CV prevention
    Date added:
    05/11/2026
    Date updated:
    05/11/2026
    Relationship end date:
    12/31/2026
Return to 2026 Inova Fairfax Medicine Grand Rounds: From Idea to Data to Discovery to Deployment -- Engineering the Future of Cardiovascular Health Care Delivery and Research